ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,899.82
-0.27%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. EOM Pharmaceutical Holdings Inc (PK) (IMUC)

  7. EOM Pharmaceutical Holdings Inc (PK) (IMUC) Noticias

IMUC

EOM Pharmaceutical (PK) (IMUC)

EOM Pharmaceutical Holdings Inc (PK)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:IMUC
FechaHoraFuenteTítuloSímboloCompañía
02/08/202314:11Edgar (US Regulatory)Form RW - Registration Withdrawal RequestUSOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
20/12/202205:11Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
12/09/202215:02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
24/06/202214:30Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
16/11/201805:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
06/11/201816:18Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
06/11/201816:12Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
06/11/201816:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
17/10/201805:33Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
13/08/201816:17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
13/08/201808:50Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
08/06/201815:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
14/03/201816:26Edgar (US Regulatory)Annual Report (10-k)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
13/02/201805:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
15/11/201715:47Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
31/07/201705:09Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
20/07/201715:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
28/04/201715:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
28/04/201715:24Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
24/04/201705:09Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
17/04/201715:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
15/11/201605:23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
08/08/201606:23Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
04/08/201605:10Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
20/01/201605:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
30/12/201505:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
22/09/201516:26Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
19/11/201405:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:IMUCEOM Pharmaceutical Holdings Inc (PK)
24/12/201307:45Dow Jones NewsBOND REPORT: Tesla Gains After Safety Rating; Supernus SurgesUSOTC:IMUCImmunoCellular Therapeutics Ltd.
15/11/201307:53Dow Jones NewsD. E. Shaw & Co. LP 3Q 13F: Largest EliminationsUSOTC:IMUCImmunoCellular Therapeutics Ltd.
 Showing the most relevant articles for your search:USOTC:IMUC

Su Consulta Reciente

LSE
43WS
Elenia Ver. 34
EU
DEUAD
Departement de L Eure 0....
BIT
I09815
IT0005574402 20240603 20
BIT
NSCITA1Z99L4
European Stability Mecha...
NASDAQ
GBLIL
Global Indemnity
ASX
LAM
Laramide Resources
ASX
CSRKOP
NASDAQ
CRDMX
Griffin Institutional Ac...
BOV
AXPB34R
American Express
LSE
77AV
Well Far Fin 25
LSE
34TV
Euro.bk. 23
HITB
BURGERUSDT
Burger Swap
ASX
TLSKOJ
NASDAQ
CCGDX
American Funds 2070 Targ...
DBI
CXPP
DAXsector Pharma and Hea...
AMEX
APLY
Yieldmax Aapl Option Inc...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados